Merrimack Pharma (MACK) – Analyst Comments
-
Merrimack Pharmaceuticals (MACK) PT Lowered to $4 at Baird as MM-121 Disappoints
-
UPDATE: Merrimack Pharmaceuticals (MACK) PT Lowered to $7 at Baird
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to MACK Stock Lookup